Afexa Life Sciences Inc.
TSX : FXA

Afexa Life Sciences Inc.

November 24, 2009 08:00 ET

Afexa Appoints Two New Members to Its Board of Directors

EDMONTON, ALBERTA--(Marketwire - Nov. 24, 2009) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA) maker of COLD-FX®, announced the appointment of John A. Rogers and William B. White to its Board of Directors to fill two vacancies.

Mr. Rogers has had a distinguished career, including 32 years in senior management positions with MDS Inc., a global life sciences company, and MDS Capital, a life sciences venture capital company. He retired from his position as President of MDS Inc. in June of 2005. Since 1973 Mr. Rogers has held a number of senior management roles within MDS Inc., enjoying a steady progression through the ranks. Mr. Rogers is a recipient of the Rotman Distinguished Business Alumni Award from the University of Toronto's Rotman School of Management – the highest honour bestowed upon graduates of the School. He attended the Advanced Management program at Harvard University, is a Fellow of the Institute of Chartered Accountants, and received a B.A., Commerce from the University of Toronto. He serves as a member of the Board of Directors of several public and private organizations. 

William White is the retired President of DuPont Canada. DuPont is a science company offering a wide range of products and services and operating in more than 70 countries. He held a variety of leadership roles in the global business unit over his 34 years with DuPont. Prior to his 2006 appointment as President of DuPont Canada, Mr. White worked across the corporation leading programs focused on growth through marketing and sales transformation, developing emerging markets, and step-change business strategies. He was director of Business Improvement at DuPont's headquarters in Wilmington, Delaware, before being promoted to president of DuPont Canada. He is currently a partner in CBW Associates which is a Canadian business consulting firm. A graduate of Purdue University in West Lafayette, Indiana (B.Sc., Mechanical Engineering), he is a 2009 Distinguished Engineering Alumnus and chairs Purdue's Mechanical Engineering advisory committee. Mr. White also serves on the Board of Directors of a number of non-profit boards.

"Afexa Life Sciences is an innovative and forward looking Company, and our lead product COLD-FX is a remarkable success in the marketplace. Our strategic plans and rigorous product- development pipeline require that we have Board members with deep and diverse business experience, leadership skills and financial acumen to harmonize with the existing skills on our Board. We have found these qualities and skills in these two gentlemen and we welcome John and Bill to our Board," said Afexa's Executive Chairman, Jack Moffatt.

The appointments are effective immediately and bring the Board complement to seven.

About Afexa Life Sciences Inc.

Afexa Life Sciences Inc. (formerly CV Technologies) founded in 1992 strives to transform people's lives to be healthier and happier by focusing on prevention and recovery through the use of evidence-based naturally-derived health products. The Company's lead product COLD-FX® strengthens the immune system and is widely used as a leading over the counter remedy ("OTC") for helping to prevent and relieve cold and flu infections.

Contact Information